Rice Hall James & Associates’s Vericel VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2M Buy
279,677
+140,837
+101% +$6.1M 0.6% 53
2026
Q2
$6.18M Buy
138,840
+6,777
+5% +$244K 0.3% 84
2026
Q1
$4.25M Buy
132,063
+2,094
+2% +$74.4K 0.24% 92
2025
Q4
$4.68M Buy
129,969
+120,013
+1,205% +$4.41M 0.26% 87
2025
Q3
$313K Buy
+9,956
New +$357K 0.02% 240

Other funds holding VCEL

Rice Hall James & Associates's VCEL Position: Q3 2026 in Review

Rice Hall James & Associates increased its Vericel (VCEL) stake by 101% in Q3 2026, buying an estimated $6.1M and bringing the position to 279,677 shares worth $11.2M. The position accounts for 0.6% of the portfolio, ranked #53.

Rice Hall James & Associates first reported a position in VCEL in Q3 2025 and has held it in 5 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q3 2026.

  • Rice Hall James & Associates held 279,677 shares of Vericel worth $11.2M as of Q3 2026.
  • Rice Hall James & Associates bought 140,837 Vericel shares in Q3 2026, an estimated $6.1M.
  • Vericel made up 0.6% of Rice Hall James & Associates's portfolio in Q3 2026, its #53 holding.
  • Rice Hall James & Associates first reported a position in Vericel in Q3 2025 and has held it in 5 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel as of Q3 2026.

Based on Rice Hall James & Associates's 13F filing for Q3 2026, filed 16 Nov 2026.